Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02717130 · ClinicalTrials.gov registry record · NA
Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
A NA study, sponsored by Florida Atlantic University.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02717130 is a NA study that was terminated before completion, run by Florida Atlantic University. The registered enrollment target is 9 participants.
The verdict
NCT02717130, a NA study, was terminated before completion, sponsored by Florida Atlantic University.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
An Open-label, Multi-center, Longitudinal, Within-subject Comparison Study to Evaluate the Effects of Aripiprazole Once Monthly in Subjects with Schizophrenia on 30-, 90-, and 180- day Re-hospitalization Rates Following Hospital Discharge Compared with Retrospective Re-hospitalization Rates while on Oral Antipsychotic Medication.
Interventions
- DRUG Aripiprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2016-06-08 |
| Est. Completion | 2017-05-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02717130
The ClinicalTrials.gov registry entry for NCT02717130 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida Atlantic University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aripiprazole is the first listed.
NCT02717130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02717130 about?
NCT02717130 is a clinical study titled "Aripiprazole, Abilify Maintena Collaborative Clinical Protocol". An Open-label, Multi-center, Longitudinal, Within-subject Comparison Study to Evaluate the Effects of Aripiprazole Once Monthly in Subjects with Schizophrenia on 30-, 90-, and 180- day Re-hospitalization Rates Following Hospital Discharge Compared with Retrospective Re-hospitalization Rates while on...
What is the current status of trial NCT02717130?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2016-06-08. Estimated completion is 2017-05-25.
What interventions are being tested in trial NCT02717130?
The interventions under investigation include: Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT02717130?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.